SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-023103
Filing Date
2021-02-01
Accepted
2021-01-29 21:20:01
Documents
15
Period of Report
2021-01-29
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d113231d8k.htm   iXBRL 8-K 23416
2 EX-5.1 d113231dex51.htm EX-5.1 17580
6 GRAPHIC g113231g0130042912728.jpg GRAPHIC 1785
7 GRAPHIC g113231g80c59.jpg GRAPHIC 2291
  Complete submission text file 0001193125-21-023103.txt   176719

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA grts-20210129.xsd EX-101.SCH 3096
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE grts-20210129_lab.xml EX-101.LAB 18887
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grts-20210129_pre.xml EX-101.PRE 11877
8 EXTRACTED XBRL INSTANCE DOCUMENT d113231d8k_htm.xml XML 3467
Mailing Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608
Business Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608 (510) 871-6100
Gritstone Oncology, Inc. (Filer) CIK: 0001656634 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38663 | Film No.: 21573966
SIC: 2836 Biological Products, (No Diagnostic Substances)